1. Home
  2. PRDO vs BEAM Comparison

PRDO vs BEAM Comparison

Compare PRDO & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perdoceo Education Corporation

PRDO

Perdoceo Education Corporation

HOLD

Current Price

$28.18

Market Cap

2.3B

Sector

Real Estate

ML Signal

HOLD

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

HOLD

Current Price

$26.80

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRDO
BEAM
Founded
1994
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.3B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
PRDO
BEAM
Price
$28.18
$26.80
Analyst Decision
Buy
Strong Buy
Analyst Count
1
12
Target Price
$42.00
$48.09
AVG Volume (30 Days)
841.9K
2.1M
Earning Date
11-04-2025
11-04-2025
Dividend Yield
2.13%
N/A
EPS Growth
17.26
N/A
EPS
2.33
N/A
Revenue
$810,888,000.00
$55,701,000.00
Revenue This Year
$26.43
N/A
Revenue Next Year
$3.65
$26.52
P/E Ratio
$12.11
N/A
Revenue Growth
24.23
N/A
52 Week Low
$23.87
$13.53
52 Week High
$38.03
$35.25

Technical Indicators

Market Signals
Indicator
PRDO
BEAM
Relative Strength Index (RSI) 34.23 57.99
Support Level $27.56 $23.30
Resistance Level $28.59 $29.16
Average True Range (ATR) 0.90 1.71
MACD 0.17 0.52
Stochastic Oscillator 45.21 73.17

Price Performance

Historical Comparison
PRDO
BEAM

About PRDO Perdoceo Education Corporation

Perdoceo Education Corp is an American for-profit education company that focuses on quality postsecondary education online to a diverse student population, along with campus-based and blended learning programs. The company's important segments include the American InterContinental University, the University of St. Augustine for Health Sciences, and Colorado Technical University. These universities provide undergraduate, graduate, and doctoral degree programs focusing on business, technology, management, and social services, with the majority of the students enrolled in programs offered fully online. The majority of the company's revenue comes from the Colorado Technical University segment.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.

Share on Social Networks: